Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Guiyang launches the first vaccination ceremony for the Omicron sequential vaccination of the elderly
Published Time：
2022-12-12
On December 12, at 2:30 pm, the first dose ceremony for the sequential booster vaccination of the Zhuhai Lizhu recombinant novel coronavirus fusion protein vaccine was held in Guiyang.
It is understood that the launch of this vaccination activity is to implement the overall requirements of the Guizhou Provincial Center for Disease Control and Prevention on accelerating the improvement of the vaccination rate among people over 80 years old and continuing to improve the vaccination rate among people aged 60-79, so as to mobilize social forces to jointly participate in mobilizing the elderly for sequential vaccination of the new coronavirus vaccine. By "mixing and matching" new coronavirus vaccines produced using different biotechnology routes to achieve complementary advantages, compensating for the side effects of a single vaccine, and thus effectively preventing the risk of Omicron infection among the elderly population.
As of the seventh national population census data in 2020, among the permanent residents of Guizhou Province, the elderly aged 60 and above account for about 15.38% of the total population of the province, reaching 5.93 million people. For this group of people, sequential vaccination of the new coronavirus vaccine undoubtedly provides an effective guarantee for disease prevention in the healthy life of the elderly in their later years.
With the deepening of research on the novel coronavirus, the data from phase III clinical trials targeting Omicron (a variant of the novel coronavirus) have gradually improved. Currently, the recombinant novel coronavirus fusion protein vaccine has an absolute protective efficacy as high as 61.35%, and the age limit for vaccination will be completely lifted after the first dose of sequential vaccination.
At the event site, the staff of the vaccination clinic conducted relevant epidemiological inquiries for the people participating in the sequential vaccination, and at the same time recorded whether there were any underlying diseases or contraindications. "I heard that this booster vaccine is very effective against the current Omicron variant. I'm getting older, so I'm still afraid of being infected." said Mr. Huang, 60, after receiving the protein vaccine. "I didn't feel any pain when I received this booster vaccine, and I observed for half an hour without any discomfort. I feel good now."
According to statistics, most of the recipients in this activity chose the Zhuhai Lizhu recombinant novel coronavirus fusion protein (CHO cell) vaccine. Its unique molecular design contains IFN-α biological adjuvant, which can enhance the immune response and produce higher protective efficacy. It takes effect 7 days after vaccination and reaches excellent protective effect after 14 days, and can be used for emergency vaccination.
Source: Sina.com
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.